PREVALENCE OF RENAL DISFUNCTION IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA USING FIRST AND SECOND-GENERATION TYROSINE KINASE INHIBITORS
The use of tyrosine kinase inhibitors (TKIs) have revolutionized the treatment of chronic myeloid leukemia (CML), making it possible for patients to have a life expectancy similar to that of the healthy population. To improve treatment adherence and effectiveness, it is necessary to understand the s...
Sábháilte in:
| Príomhchruthaitheoirí: | , , , , , , |
|---|---|
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe / Cruthaithe: |
Elsevier
2023-10-01
|
| Sraith: | Hematology, Transfusion and Cell Therapy |
| Rochtain ar líne: | http://www.sciencedirect.com/science/article/pii/S2531137923006181 |
| Clibeanna: |
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!
|